Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis

US9670539B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9670539-B2
Application numberUS-201514859853-A
CountryUS
Kind codeB2
Filing dateSep 21, 2015
Priority dateOct 19, 2007
Publication dateJun 6, 2017
Grant dateJun 6, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides novel azido linkers for deoxynucleotide analogs having a detectable marker attached thereto.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising: a) contacting the nucleic acid with (i) at least four different deoxynucleotide triphosphate (dNTP) analogues, each having the structure: wherein F is a fluorophore, b is a base which is adenine, guanine, cytosine, uracil or thymine, wherein the fluorophore attached through a linker to each type of base differs in its emission or excitation spectra from a fluorophore attached to each of the remaining types of bases, and each of the four dNTP analogues differs from the remaining three dNTP analogues by having a different base, wherein L is an azido cleavable linker molecule or a nitrobenzyl cleavable linker molecule, and R is a cleavable chemical group which is not hydrogen, (ii) a nucleic acid polymerase and (iii) a nucleic acid primer which hybridizes with the nucleic acid, under conditions permitting one of the four dNTP analogues that is complementary to the consecutive nucleotide residue to be identified to form a phosphodiester bond with the 3′ end of the nucleic acid primer and thereby extend the primer; b) identifying the fluorophore of the dNTP analogue which has formed the phosphodiester bond, thereby identifying the consecutive nucleotide; c) cleaving the linker attaching the fluorophore of the dNTP analogue which has formed the phosphodiester bond and cleaving the cleavable chemical group from the dNTP; d) iteratively repeating steps a) through c) for each of the consecutive nucleotide residues to be identified until the final consecutive nucleotide residue to be identified in steps a) through e); e) repeating steps a) and b) to identify the final consecutive nucleotide residue in steps a) through e); f) denaturing the extended primer so as to de-hybridize it from the nucleic acid; g) contacting the nucleic acid with (i) three different types of deoxynucleotide triphosphate (dNTP), (ii) a nucleic acid polymerase and (iii) a second nucleic acid primer which hybridizes with the nucleic acid, under conditions permitting one of the three different types of dNTP that is complementary to the consecutive nucleotide residue to be identified to form a phosphodiester bond with the 3′ end of the second nucleic acid primer and thereby extend the second nucleic acid primer; h) contacting the nucleic acid with (i) three different types of deoxynucleotide triphosphate (dNTP), wherein at least one of the types of deoxynucleotide triphosphate is not used in step g), under conditions permitting one of the three different types of dNTP that is complementary to the consecutive nucleotide residue to be identified to form a phosphodiester bond with the 3′ end of the extended second nucleic acid primer and thereby further extend the second nucleic acid primer; i) repeating steps g) and h) until the second nucleic acid primer is extended up to and including a residue corresponding to the final consecutive nucleotide residue identified in step e); j) contacting the extended second nucleic acid primer with (i) at least four different deoxynucleotide triphosphate (dNTP) analogues, each having the structure: wherein F is a fluorophore, b is a base which is adenine, guanine, cytosine, uracil or thymine, wherein the fluorophore attached through a linker to each type of base differs in its emission or excitation spectra from a fluorophore attached to each of the remaining types of bases, and each of the four dNTP analogues differs from the remaining three dNTP analogues by having a different base, wherein L is an azido cleavable linker molecule or a nitrobenzyl cleavable linker molecule, and R is a cleavable chemical group which is not hydrogen, under conditions permitting one of the four dNTP analogues that is complementary to the next consecutive nucleotide residue to be identified to form a phosphodiester bond with the 3′ end of the extended second nucleic acid primer and thereby further extend the second primer; k) identifying the fluorophore of the dNTP analogue which has formed the phosphodiester bond, thereby identifying the consecutive nucleotide; l) cleaving the fluorophore and the cleavable chemical group from the dNTP analogue which formed the phosphodiester bond so as to thereby permit incorporation of a further dNTP analogue into the extended second nucleic acid primer; m) iteratively repeating steps j) through l) for each of the consecutive nucleotide residues to be identified until the final consecutive nucleotide residue to be identified in steps j) through n); n) repeating steps j) and k) to identify the final consecutive nucleotide residue to be identified in steps j) through n); so as to thereby determining the identity of each of the series of consecutive nucleotide residues in the nucleic acid. 2. The method of claim 1 , wherein in steps g) and h) the three types of dNTPs are chosen from the group dATP, dCTP, dGTP, dTTP or dITP. 3. The method of claim 1 , wherein the linker in each of step a) and j) independently each comprise the structure: or the structure: wherein α represents a point of attachment to the base and β represents a point of attachment to the fluorophore, and wherein R is a cleavable chemical group. 4. The method of claim 1 , wherein one or more linker is cleaved by contacting the linker with tris(2-carboxyethyl)phosphine. 5. The method of claim 1 , wherein one or more linkers are photocleavable or chemically cleavable. 6. The method of claim 1 , wherein one or more chemical groups are photocleavable or chemically cleavable. 7. The method of claim 1 , wherein R in the structures set forth in steps a) and/or j) is independently chosen from an —N 3 group or an allyl group. 8. The method of claim 1 , wherein the cleavable chemical group in step g) is independently chosen from an —N 3 group or an allyl group. 9. A method for determining the identity of each of a series of consecutive nucleotide residues in a nucleic acid comprising: a) contacting the nucleic acid with (i) at least four different deoxynucleotide triphosphate (dNTP) analogues, each having the structure: wherein F is a fluorophore, b is a base which is adenine, guanine, cytosine, uracil or thymine, wherein the fluorophore attached through a linker to each type of base differs in its emission or excitation spectra from a fluorophore attached to each of the remaining types of bases, and each of the four dNTP analogues differs from the remaining three dNTP analogues by having a different base, wherein L is an azido cleavable linker molecule or a nitrobenzyl cleavable linker molecule, and R is a cleavable chemical group which is not hydrogen, (ii) a nucleic acid polymerase and (iii) a nucleic acid primer which hybridizes with the nucleic acid, under conditions permitting one of the four dNTP analogues that is complementary to the consecutive nucleotide residue to be identified to form a phosphodiester bond with the 3′ end of the nucleic acid primer and thereby extend the primer;

Assignees

Inventors

Classifications

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • Purine radicals · CPC title

  • Hairpin oligonucleotides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9670539B2 cover?
This invention provides novel azido linkers for deoxynucleotide analogs having a detectable marker attached thereto.
Who is the assignee on this patent?
Univ Columbia
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).